Avanos Medical, Inc. (NYSE:AVNS) Position Trimmed by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System lessened its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS) by 3.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,200 shares of the company’s stock after selling 900 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Avanos Medical were worth $533,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Tidal Investments LLC purchased a new position in Avanos Medical during the 1st quarter valued at about $439,000. BNP Paribas Financial Markets grew its stake in shares of Avanos Medical by 314.4% in the 1st quarter. BNP Paribas Financial Markets now owns 53,583 shares of the company’s stock valued at $1,067,000 after buying an additional 40,653 shares in the last quarter. Boston Partners bought a new stake in shares of Avanos Medical in the 1st quarter valued at approximately $571,000. Quest Partners LLC bought a new stake in shares of Avanos Medical in the 2nd quarter valued at approximately $444,000. Finally, Deerfield Management Company L.P. Series C bought a new stake in shares of Avanos Medical in the 2nd quarter valued at approximately $551,000. Hedge funds and other institutional investors own 95.17% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday.

Avanos Medical Trading Up 3.1 %

Shares of NYSE AVNS opened at $19.81 on Wednesday. The stock has a market cap of $910.47 million, a price-to-earnings ratio of 58.26 and a beta of 0.92. The business has a 50 day simple moving average of $22.96 and a 200 day simple moving average of $21.53. Avanos Medical, Inc. has a 52 week low of $17.39 and a 52 week high of $25.36. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.